Monitoring antibiotic resistance

Why is this priority? 

Resistance to antibiotics is the capacity of a micro-organism to resist the actions of antibiotics. It is a natural phenomenon which is boosted by an inappropriate use of antibiotics in human as well as in animal.

Antibiotic resistance is one of the biggest threats to global health, food security, and development today. In 2014, the World Health Organization (WHO) published a first situation report on resistance to antibiotics in 114 countries. It mentions presence of bacteria resistant to antibiotics in all the regions of the world. In European Union, the number of deaths due to the antibiorésistance is is estimated to 25,000 per year and its cost at 1.5 billion dollars of health expenditure and fall of productivity.

The World Organization for animal health (OIE), following an evaluation of the veterinary services in 110 countries, also pointed out the growing risk of antibioresistance in the majority of the developing and emerging countries.

The studies on antibioresistance in the Indian Ocean, in public or animal health, indicate that the producing enterobacteries of BLSE proved to be one of the major risk.



What is its added-value?

The monitoring of resistance to antibiotics was defined a priority by the SEGA One health technical committee. The IOC countries, thanks to the SEGA network, have an information sharing platform, laboratories in capacity to diagnose and detect antibioresistance and regional expertise.

However in animal health, the technical reference systems for the detection of antibioresistance are not yet operational. Technical capacities still need to be implemented.

The first results are expected end of 2017.